Co-administration of tyrosine kinase inhibitors with rottlerin in metastatic prostate cancer cells

After prostatectomy due to prostate carcinoma, patients often develop metastases. Although prostate cancer is susceptible to hormonal manipulation, many patients become castration-resistant. Therefore, new therapies are the focus of investigations. We analyzed the effect of the tyrosine kinase inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Cieslikowski, Wojciech A., Haber, Tobias, Krajnak, Slavomir, Anic, Katharina, Hasenburg, Annette, Mager, René, Thüroff, Joachim W., Brenner, Walburgis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678056/
https://www.ncbi.nlm.nih.gov/pubmed/34924906
http://dx.doi.org/10.17179/excli2021-3980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678056/
https://www.ncbi.nlm.nih.gov/pubmed/34924906
http://dx.doi.org/10.17179/excli2021-3980

Ejemplares similares